Extramedullary relapse confirmed by fluorescence in situ hybridization study of an ear mass in acute promyelocytic leukemia

International Journal of Hematology

Volumn 79, Issue 5, 2004, Pages 462-464

  Lee, Keun Wook ^a   Yi, Jongyoun ^a   Yun, Tak ^a   Kim, Dae Young ^a   Lee, Dong Soon ^a   Park, Sung Sup ^a   Cho, Han Ik ^a   Yoon, Sung Soo ^a,b,c   Park, Seonyang ^a   Kim, Byoung Kook ^a   Kim, Noe Kyeong ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Biomedical Research Institute   (South Korea)

^c Seoul National University Hospital   (South Korea)

Author keywords

Acute promyelocytic leukemia; Ear involvement; Extramedullary; Fluorescence in situ hybridization; PML RAR

Indexed keywords

CYTARABINE; DAUNORUBICIN; IDARUBICIN; RETINOIC ACID;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CHROMOSOME REARRANGEMENT; CYTOGENETICS; EAR TUMOR; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MALE; PROMYELOCYTIC LEUKEMIA; RELAPSE; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; BIOPSY; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 15; EAR NEOPLASMS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; NEOPLASM RECURRENCE, LOCAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 3042608158     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.A10320     Document Type: Article

References (12)

1. Weiss MA, Warrell RP Jr. Two cases of extramedullary acute promyelocytic leukemia: cytogenetics, molecular biology, and phenotypic and clinical studies. Cancer. 1994;74:1882-1886.
2. Liso V, Specchia G, Pogliani EM, et al. Extramedullary involvement in patients with acute promyelocytic leukemia: a report of seven cases. Cancer. 1998;83:1522-1528.
3. Wiernik PH, De Bellis R, Muxi P, Dutcher JP. Extramedullary acute promyelocytic leukemia. Cancer. 1996;78:2510-2514.
4. Specchia G, Lo Coco F, Vignetti M, et al. Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto. J Clin Oncol. 2001;19: 4023-4028.
5. Millot F, Klossek JM, Brizard F, et al. Recurrence of childhood acute lymphoblastic leukemia presenting as a tumor of the middle ear: a case report. J Pediatr Hematol Oncol 1997;19:351-353.
6. Tobita T, Shinjyo K, Yanagi M, Takeshita A, Ohnishi K, Ohno R. Relapse in the external auditory canal of acute promyelocytic leukemia after treatment with all-trans retinoic acid. Intern Med. 1997;36:484-486.
7. Au WY, Chan GC, Chim CS, et al. Unusual sites of involvement by hematologic malignancies: case 3, external auditory canal tumor-a rare chloroma in acute promyelocytic leukemia with a complete response to arsenic trioxide. J Clin Oncol. 2001;19:3993-3995.
8. Ustun C, Arat M, Celebi H, et al. Extramedullary relapse following allogeneic stem cell transplantation in acute promyelocytic leukemia: the role of ATRA. Haematologica. 2001;86:E31.
9. Breccia M, Petti MC, Testi AM, et al. Ear involvement in acute promyelocytic leukemia at relapse: a disease-associated "sanctuary"? Leukemia. 2002;16:1127-1130.
10. Ko BS, Tang JL, Chen YC, et al. Extramedullary relapse after alltrans retinoic acid treatment in acute promyelocytic leukemia: the occurrence of retinoic acid syndrome is a risk factor. Leukemia. 1999;13:1406-1408.
11. Lo Coco F, Diverio D, Falini B, Nervi C, Pelicci PG. Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia. Blood. 1999;94:12-22.
12. Falini B, Flenghi L, Fagioli M, et al. Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML). Blood. 1997;90:4046-4053.